Peak expiratory flow as an endpoint for clinical trials in asthma: a comparison with FEV(1)

BACKGROUND: The primary lung function endpoint in clinical trials in adolescent and adult patients with asthma is usually forced expiratory volume in one second (FEV(1)). The objective of our analysis was to assess whether peak expiratory flow (PEF) is a suitable alternative primary lung function en...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Respir Res
Autores principales: Halpin, David M. G., Meltzer, Eli O., Pisternick-Ruf, Wendelgard, Moroni-Zentgraf, Petra, Engel, Michael, Zaremba-Pechmann, Liliana, Casale, Thomas, FitzGerald, J. Mark
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6637596/
https://ncbi.nlm.nih.gov/pubmed/31319851
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-019-1119-6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares